Measuring Motor Imagery Ability in Patients With Traumatic Brain Injury.

May 6, 2019 updated by: University Ghent
  1. Validation of translated Motor Imagery ability questionnaire MIQ-RS
  2. Investigating the Motor Imagery ability in patients with traumatic brain injury

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. Translation of the MIQ-RS following the WHO guidelines. Followed by a validation of this translated questionnaire in patients with traumatic brain injury and in healthy volunteers.

  2. Investigating the motor imagery ability using 3 different test

    • MIQ-RS (movement imagery questionnaire)
    • TDMI (time dependent motor imagery)
    • mental chronometry test

Patients and controls will perform all 3 test twice with an interval of 2 weeks to measure the test-retest reliability.

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Ghent, Belgium, 9000
        • Ghent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • TBI minimum 3 months ago and maximal 1 year ago

Exclusion Criteria:

  • Other neurological disorders
  • Severe cognitive deficits, unable to understand the study protocol
  • Severe motor impairment, unable to perform the TDMI (Time Dependent Motor Imagery) screening test

Control group:

Matched for age, sex and educational level No neurological disorders present

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Traumatic brain injury

Patients who have suffered a traumatic brain injury will be assessed with a test battery including

  • a motor imagery ability questionnaire (MIQ-rs)
  • a mental rotation test
  • a chronometry test (TDMI)
Other: Test battery to measure the motor imagery ability
Participants will perform 3 different tests to measure the motor imagery ability
ACTIVE_COMPARATOR: Control

Healthy volunteers matched for age, sex and educational level will be assessed with the same test battery including

  • a motor imagery ability questionnaire (MIQ-RS)
  • a mental rotation test
  • a chronometry test (TDMI)
Other: Test battery to measure the motor imagery ability
Participants will perform 3 different tests to measure the motor imagery ability

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor imagery ability
Time Frame: 2 assessments with an interval of 2 weeks
Results of test battery assessing motor imagery ability
2 assessments with an interval of 2 weeks
Validity translated MIQ-RS
Time Frame: 2 assessments with an interval of 2 weeks
Validity of the translated MIQ-RS in patients with traumatic brain injury and healthy volunteers
2 assessments with an interval of 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test-retest reliability
Time Frame: 2 assessments with an interval of 2 weeks
Test- retest reliability of the motor imagery ability test battery
2 assessments with an interval of 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Ghent

Collaborators

University Hospital, Ghent

Investigators

  • Principal Investigator: Kristine Oostra, MD, University Hospital, Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 7, 2017

Primary Completion (ACTUAL)

October 30, 2018

Study Completion (ACTUAL)

October 30, 2018

Study Registration Dates

First Submitted

October 3, 2017

First Submitted That Met QC Criteria

October 16, 2017

First Posted (ACTUAL)

October 20, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 7, 2019

Last Update Submitted That Met QC Criteria

May 6, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EC/2017/0826

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe